Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Amphista Therapeutics

Biotech & Life Sciences · Great Abington, United Kingdom · Founded 2017 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$100–500M
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

10 investors on Amphista Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Advent Life Sciences
European Investment Fund
BioMotiv
Scottish Enterprise Growth Investments
Series B+ 6 investors entered at this stage
Eli Lilly
Gilde Healthcare
Novartis Venture Fund
University of Dundee
Dementia Discovery Fund
Forbion Capital Partners

Global footprint

Where Amphista Therapeutics has talent and traffic

Web traffic by country
2K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

See Amphista Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo